Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+132.4%
Year-over-Year Change
Year-over-year net income growth rate
5Y CAGR
+132.4%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
67.7x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 212.79% |
| 2024 | 36.82% |
| 2023 | 61.08% |
| 2022 | -32.64% |
| 2021 | 0.64% |
| 2020 | 3.14% |
| 2019 | -16.37% |
| 2018 | -55.13% |
| 2017 | -19.69% |
| 2016 | -41.38% |